HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Data Supplement All Versions of this Article: 01.wnl.0000275524.15125.f4v1 69/18/1745    most recent Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Winkler, S. Articles by Klein, C. Search for Related Content PubMed PubMed Citation Articles by Winkler, S. Articles by Klein, C. Related Collections Parkinson's disease/Parkinsonism All Genetics Association studies in genetics

-Synuclein and Parkinson disease susceptibility

From the Departments of Neurology (S.W., J.H., K.L.-H., C.K.) and Human Genetics (S.W., K.L.-H., C.K.), University of Lübeck, Lübeck, Germany; Department of Neuroscience, Mayo Clinic, Jacksonville, FL (S.L., M.H., K.H., M.F.); and Department of Neurology, University of Belgrade, Belgrade, Serbia and Montenegro (V.K.).

Address correspondence and reprint requests to Dr. Christine Klein, Department of Neurology, University of Lübeck; Ratzeburger Allee 160, 23538 Lübeck, Germany christine.klein{at}neuro.uni-luebeck.de

Background: Mutations in the -synuclein (SNCA) gene have been shown to be responsible for a rare familial form of Parkinson disease (PD). Furthermore, polymorphic variants in multiple regions of the gene have been associated with susceptibility to idiopathic PD in different populations.

Objective: To evaluate and to confirm the role of SNCA variants in PD pathogenesis.

Methods: We included 667 subjects (397 cases with idiopathic PD and 270 healthy, ethnically matched controls) of Northern Central and Southeastern European origin. We analyzed genotypes at 14 markers spanning the SNCA locus and its major haplotype blocks and conducted a haplotype analysis for four promoter markers including the microsatellite marker Rep1.

Results: The three single nucleotide polymorphisms (SNPs) of the promoter region (rs2583988, rs2619364, rs2619363) and a SNP in the 3'UTR (rs356165) of the SNCA gene showed the greatest evidence for an association with PD (p 0.003), with significant pairwise values for linkage disequilibrium (D' 0.74, r ² 0.29). The promoter haplotype "261-T-G-T" (Rep1-rs2583988-rs2619364-rs2619363) was associated with disease (p = 0.032). The most significant association with PD was generated by excluding Rep1 (p = 0.008). This association remained significant when analyzing the Serbian patients separately and was of borderline significance for the German patients.

Conclusions: Our findings confirm that genetic variability within the SNCA locus is associated with susceptibility to idiopathic Parkinson disease (PD). We found evidence for disease association with single nucleotide polymorphisms at both the 5' and the 3' end of the gene with pairwise linkage disequilibrium between them. The association was independent of the Rep1 status, and one major SNCA promoter haplotype class seems to be associated with PD susceptibility.

GLOSSARY: SNCA = -synuclein; CI = confidence interval; HT = haplotype-tagging; LD = linkage disequilibrium; OR = odds ratio; PD = Parkinson disease; SNP = single nucleotide polymorphism.

Supplemental data at www.neurology.org

e-Pub ahead of print on September 12, 2007, at www.neurology.org.

Supported by a grant from the Deutsche Forschungsgemeinschaft, the PD Foundation/National Parkinson Foundation, the Bundesministerium für Bildung und Forschung, and the University Lübeck (all to C.K.). C.K. is supported by the VolkswagenStiftung. The Morris K. Udall Center for Excellence (NIH P50 NS40256) supports Parkinson disease research at Mayo Clinic.

Disclosure: The authors report no conflicts of interest.

Received February 15, 2007. Accepted in final form May 21, 2007.

This article has been cited by other articles:

				K. D. Cronin, D. Ge, P. Manninger, C. Linnertz, A. Rossoshek, B. M. Orrison, D. J. Bernard, O. M.A. El-Agnaf, M. G. Schlossmacher, R. L. Nussbaum, et al. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human {alpha}-synuclein in transgenic mouse brain Hum. Mol. Genet., September 1, 2009; 18(17): 3274 - 3285. [Abstract] [Full Text] [PDF]

				K. Marek and D. Jennings Can we image premotor Parkinson disease? Neurology, February 17, 2009; 72(7_Supplement_2): S21 - S26. [Abstract] [Full Text] [PDF]

				M. J. Farrer Lrrk2 in the limelight! Neurology, October 30, 2007; 69(18): 1732 - 1733. [Full Text] [PDF]